May 07 2007

Any Cell Type From Adult Stem Cells

Published by at 11:57 am under All General Discussions,Stem Cell Debate

Want to know how many types of cells can be created from Adult Stem Cell procedures? Answer: All of them:

PrimeCell Therapeutics’ researchers have taken adult stem cells from mouse testes, the germ line, and reprogrammed them to exhibit pluripotentiality – the ability to transform into any other cell type in the body. Using human cells, PrimeCell Therapeutics has already therapeutically reprogrammed adult germ cells into human heart, brain, bone and cartilage cells.

The germ line is the most protected and genetically pure cell line in the body and, as such, provides the best chance for successful and highly effective therapies. For therapy, the cells would be derived from the same individual receiving the therapeutic treatment, eliminating risk of rejection, infection and the introduction of foreign pathogens – and possibly reducing the time to regulatory approval for clinical trials.

Want to know how many cell types have been created from Embryonic Stem Cells? Answer: zero. There is no scientific need to kill young human beings for spare parts. Your body provides all the material needed, and it includes YOUR genetic codes.

3 responses so far

3 Responses to “Any Cell Type From Adult Stem Cells”

  1. Soothsayer says:

    Is this a paid for ad by PriceCell? I notice they’re looking for funding from US TAXPAYERS . . . so I’m sure all their claims are totally verifiable . . .

  2. Mike M. says:

    They quite probably are… AJ has mentioned, a large part of the ESCR push is financial.

    The big benefit of ASCR is that you walk completely around the rejection issue….which a lot of people have shoved down the Memory Hole. Anti-rejection medications have a significant down-side.

    Quite aside from avoiding nasty ethical decisions….which can come back to bite you in a variety of unpleasant ways.

  3. Retired Spook says:

    Anti-rejection medications have a significant down-side.

    Roger that, Mike. My 6-year-old grandson will take them for the rest of his life because of the kidney transplant he received at 20 months. There is also a definite up-side — to the pharmaceutical companies: they’re extremely profitable.